×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Nuvalent Inc. (NUVL) NASDAQ

$75.09 (1.55) (-2.02%)

Market Cap: $4.49B

As of 03/28/24 04:00 PM EDT. Market closed.

(NUVL)

Nuvalent Inc. (NUVL)
NASDAQ

$75.09
(1.55) (-2.02%)

Market Cap: $4.49B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

nuvalent is improving human health by developing breakthrough small molecule therapeutics that engage biological targets in new ways using cutting-edge chemical insights. by expanding the universe of targets that interact with small molecules, we are generating therapeutics with activities not previously possible, including modulation of ‘undruggable’ targets. our unique approach is leading ... read more

nuvalent is improving human health by developing breakthrough small molecule therapeutics that engage biological targets in new ways using cutting-edge chemical insights. by expanding the universe of targets that interact with small molecules, we are generating therapeutics with activities not previously possible, including modulation of ‘undruggable’ targets. our unique approach is leading to first-in-class and best-in-class small molecule therapeutics that will significantly impact patient’s lives. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Full Time Employees
74
URL
Address
.
PRICE CHART FOR NUVALENT INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$75.39
Previous Close
$76.64
Days Range
$75.54 - $77.45
52 week range
$23.10 - $89.39
Volume
713,785
Avg. Volume (30 days)
445,994
Market Cap
$4.49B
Dividend Yield
-
P/E
-
Shares Outstanding
58,632,384
Open
$75.39
Previous Close
$76.64
Days Range
$75.54 - $77.45
52 week range
$23.10 - $89.39
Volume
713,785
Avg. Volume (30 days)
445,994
Market Cap
$4.49B
Dividend Yield
-
P/E
-
Shares Outstanding
58,632,384
FINANCIAL STATEMENTS FOR NUVALENT INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR NUVALENT INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Shair MatthewDirectorMar 25, 2024 Sale$76.772,000153,546238,627Mar 27, 2024, 04:55 PM
Shair MatthewDirectorMar 25, 2024 Sale$76.7737,5002,878,9821,689,153Mar 27, 2024, 04:55 PM
Noci DarleneChief Development OfficerMar 22, 2024 Option Exercise$7.7420,000154,80053,300Mar 25, 2024, 04:49 PM
Noci DarleneChief Development OfficerMar 22, 2024 Sale$77.5120,0001,550,22940,200Mar 25, 2024, 04:49 PM
Conley EmilyDirectorMar 15, 2024 Option Exercise$9.3613,333124,79713,341Mar 19, 2024, 04:46 PM
Conley EmilyDirectorMar 15, 2024 Sale$80.9213,3331,078,88311,214Mar 19, 2024, 04:46 PM
Shair MatthewDirectorDec 28, 2023 Sale$75.4648,5483,663,4921,738,190Dec 28, 2023, 05:09 PM
Shair MatthewDirectorDec 27, 2023 Sale$75.171,00075,1701,773,246Dec 28, 2023, 05:09 PM
Shair MatthewDirectorDec 26, 2023 Sale$75.1269,6025,228,3451,842,911Dec 28, 2023, 05:09 PM
Protopapas AnnaDirectorDec 18, 2023 Option Exercise$9.365,00046,8005,000Dec 20, 2023, 04:58 PM
Protopapas AnnaDirectorDec 18, 2023 Sale$75.675,000378,3500Dec 20, 2023, 04:58 PM
Noci DarleneChief Development OfficerDec 18, 2023 Option Exercise$4.7040,000188,13940,000Dec 20, 2023, 04:56 PM
Noci DarleneChief Development OfficerDec 18, 2023 Sale$75.8240,0003,032,8000Dec 20, 2023, 04:56 PM
Miller Deborah AnnChief Legal OfficerDec 19, 2023 Option Exercise$18.935,00094,6505,000Dec 20, 2023, 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 18, 2023 Option Exercise$27.8533,046920,33133,046Dec 20, 2023, 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 19, 2023 Sale$75.005,000375,0000Dec 20, 2023, 04:54 PM
Miller Deborah AnnChief Legal OfficerDec 18, 2023 Sale$75.8233,0462,505,5480Dec 20, 2023, 04:54 PM
Balcom AlexandraChief Financial OfficerDec 18, 2023 Option Exercise$1.0830,00032,40030,000Dec 20, 2023, 04:51 PM
Balcom AlexandraChief Financial OfficerDec 18, 2023 Sale$75.8230,0002,274,6000Dec 20, 2023, 04:51 PM
Shair MatthewDirectorNov 28, 2023 Sale$61.899,150566,3031,846,646Nov 30, 2023, 04:47 PM
Noci DarleneChief Development OfficerNov 01, 2023 Option Exercise$1.083,0003,2403,000Nov 03, 2023, 04:43 PM
Noci DarleneChief Development OfficerNov 01, 2023 Sale$52.663,000157,9752,913Nov 03, 2023, 04:43 PM
Shair MatthewDirectorOct 24, 2023 Sale$50.7091,7004,648,8721,863,167Oct 26, 2023, 04:47 PM
Turner Christopher DurantChief Medical OfficerOct 04, 2023 Option Exercise$6.897,99555,08622,508Oct 06, 2023, 04:58 PM
Turner Christopher DurantChief Medical OfficerOct 04, 2023 Sale$54.047,995432,03119,843Oct 06, 2023, 04:58 PM
Noci DarleneChief Development OfficerOct 04, 2023 Option Exercise$5.5620,000111,15020,000Oct 06, 2023, 04:56 PM
Noci DarleneChief Development OfficerOct 04, 2023 Sale$55.9920,0001,119,7025,400Oct 06, 2023, 04:56 PM
Noci DarleneChief Development OfficerOct 02, 2023 Option Exercise$1.083,0003,2403,000Oct 04, 2023, 04:24 PM
Noci DarleneChief Development OfficerOct 02, 2023 Sale$45.883,000137,6492,255Oct 04, 2023, 04:24 PM
Miller Deborah AnnChief Legal OfficerSep 15, 2023 Option Exercise$6.892,00013,7802,000Sep 19, 2023, 04:45 PM
Miller Deborah AnnChief Legal OfficerSep 15, 2023 Sale$47.642,00095,283756Sep 19, 2023, 04:45 PM
Noci DarleneChief Development OfficerSep 01, 2023 Option Exercise$1.083,0003,2403,000Sep 06, 2023, 04:36 PM
Noci DarleneChief Development OfficerSep 01, 2023 Sale$46.563,000139,6921,800Sep 06, 2023, 04:36 PM
Miller Deborah AnnChief Legal OfficerAug 15, 2023 Option Exercise$6.892,00013,7802,000Aug 17, 2023, 04:29 PM
Miller Deborah AnnChief Legal OfficerAug 15, 2023 Sale$42.652,00085,310709Aug 17, 2023, 04:29 PM
Noci DarleneChief Development OfficerAug 01, 2023 Option Exercise$1.083,0003,2403,000Aug 01, 2023, 05:26 PM
Noci DarleneChief Development OfficerAug 01, 2023 Sale$49.953,000149,8442,036Aug 01, 2023, 05:26 PM
Balcom AlexandraChief Financial OfficerJul 31, 2023 Option Exercise$1.0825,00027,00025,000Aug 01, 2023, 04:16 PM
Balcom AlexandraChief Financial OfficerJul 31, 2023 Sale$48.9925,0001,224,79610,848Aug 01, 2023, 04:16 PM
Miller Deborah AnnChief Legal OfficerJul 28, 2023 Option Exercise$6.896,50044,7856,500Aug 01, 2023, 04:13 PM
Miller Deborah AnnChief Legal OfficerJul 28, 2023 Sale$48.526,500315,3800Aug 01, 2023, 04:13 PM
Turner Christopher DurantChief Medical OfficerJul 26, 2023 Option Exercise$6.892,36516,29516,878Jul 28, 2023, 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 28, 2023 Option Exercise$6.892,66518,36217,178Jul 28, 2023, 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 28, 2023 Sale$48.932,665130,39814,513Jul 28, 2023, 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 26, 2023 Sale$46.852,365110,80014,513Jul 28, 2023, 04:51 PM
Turner Christopher DurantChief Medical OfficerJul 24, 2023 Option Exercise$6.892001,37814,713Jul 24, 2023, 04:54 PM
Turner Christopher DurantChief Medical OfficerJul 20, 2023 Option Exercise$6.8910068914,613Jul 24, 2023, 04:54 PM
Turner Christopher DurantChief Medical OfficerJul 24, 2023 Sale$46.822009,36414,513Jul 24, 2023, 04:54 PM
Turner Christopher DurantChief Medical OfficerJul 20, 2023 Sale$46.801004,68014,513Jul 24, 2023, 04:54 PM
Noci DarleneChief Development OfficerJul 20, 2023 Option Exercise$1.0810,94111,81610,941Jul 21, 2023, 04:47 PM
Noci DarleneChief Development OfficerJul 19, 2023 Option Exercise$1.084,5594,9244,559Jul 21, 2023, 04:47 PM
Noci DarleneChief Development OfficerJul 19, 2023 Sale$45.044,559205,3370Jul 21, 2023, 04:47 PM
Noci DarleneChief Development OfficerJul 20, 2023 Sale$45.1710,941494,2050Jul 21, 2023, 04:47 PM
Miller Deborah AnnChief Legal OfficerJul 17, 2023 Option Exercise$6.892,00013,7802,000Jul 19, 2023, 04:43 PM
Miller Deborah AnnChief Legal OfficerJul 17, 2023 Sale$43.062,00086,1231,838Jul 19, 2023, 04:43 PM
Noci DarleneChief Development OfficerJul 03, 2023 Option Exercise$1.083,0003,2403,000Jul 06, 2023, 04:51 PM
Noci DarleneChief Development OfficerJul 03, 2023 Sale$41.483,000124,427553Jul 06, 2023, 04:51 PM
Noci DarleneChief Development OfficerJun 16, 2023 Option Exercise$1.082,9003,1322,900Jun 20, 2023, 04:45 PM
Noci DarleneChief Development OfficerJun 15, 2023 Option Exercise$1.081,0001,0801,000Jun 20, 2023, 04:45 PM
Noci DarleneChief Development OfficerJun 16, 2023 Sale$45.192,900131,0510Jun 20, 2023, 04:45 PM
Noci DarleneChief Development OfficerJun 15, 2023 Sale$45.071,00045,0700Jun 20, 2023, 04:45 PM
Miller Deborah AnnChief Legal OfficerJun 15, 2023 Option Exercise$6.892,00013,7802,000Jun 20, 2023, 04:42 PM
Miller Deborah AnnChief Legal OfficerJun 15, 2023 Sale$44.282,00088,5651,805Jun 20, 2023, 04:42 PM
Turner Christopher DurantChief Medical OfficerJun 05, 2023 Option Exercise$6.8910,23570,51924,748Jun 07, 2023, 04:50 PM
Turner Christopher DurantChief Medical OfficerJun 05, 2023 Sale$44.8610,235459,14214,513Jun 07, 2023, 04:50 PM
Noci DarleneChief Development OfficerJun 05, 2023 Option Exercise$1.08600648600Jun 07, 2023, 04:46 PM
Noci DarleneChief Development OfficerJun 05, 2023 Sale$45.0060027,0000Jun 07, 2023, 04:46 PM
Noci DarleneChief Development OfficerJun 01, 2023 Option Exercise$1.083,0003,2403,000Jun 02, 2023, 04:45 PM
Noci DarleneChief Development OfficerJun 01, 2023 Sale$42.643,000127,9212,761Jun 02, 2023, 04:45 PM
Miller Deborah AnnChief Legal OfficerMay 15, 2023 Option Exercise$6.892,00013,7802,000May 17, 2023, 04:44 PM
Miller Deborah AnnChief Legal OfficerMay 15, 2023 Sale$40.742,00081,4891,498May 17, 2023, 04:44 PM
Miller Deborah AnnChief Legal OfficerMay 09, 2023 Option Exercise$6.891,3329,1771,332May 09, 2023, 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 05, 2023 Option Exercise$6.892,80019,2922,800May 09, 2023, 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 09, 2023 Sale$39.631,33252,7870May 09, 2023, 05:11 PM
Miller Deborah AnnChief Legal OfficerMay 05, 2023 Sale$39.642,800110,9920May 09, 2023, 05:11 PM
Noci DarleneChief Development OfficerMay 01, 2023 Option Exercise$1.083,0003,2403,000May 03, 2023, 04:41 PM
Noci DarleneChief Development OfficerMay 01, 2023 Sale$38.603,000115,7872,972May 03, 2023, 04:41 PM
Miller Deborah AnnChief Legal OfficerMay 01, 2023 Option Exercise$6.899006,201900May 03, 2023, 04:38 PM
Miller Deborah AnnChief Legal OfficerMay 01, 2023 Sale$39.6190035,6490May 03, 2023, 04:38 PM
Miller Deborah AnnChief Legal OfficerApr 17, 2023 Option Exercise$6.892,00013,7802,000Apr 19, 2023, 04:46 PM
Miller Deborah AnnChief Legal OfficerApr 17, 2023 Sale$30.102,00060,1971,875Apr 19, 2023, 04:46 PM
Noci DarleneChief Development OfficerApr 03, 2023 Option Exercise$1.083,0003,2403,000Apr 05, 2023, 04:40 PM
Noci DarleneChief Development OfficerApr 03, 2023 Sale$26.593,00079,765112Apr 05, 2023, 04:40 PM
Miller Deborah AnnChief Legal OfficerMar 15, 2023 Option Exercise$6.892,00013,7802,000Mar 17, 2023, 04:38 PM
Miller Deborah AnnChief Legal OfficerMar 15, 2023 Sale$28.252,00056,509161Mar 17, 2023, 04:38 PM
Noci DarleneChief Development OfficerFeb 02, 2023 Option Exercise$1.083,0003,2403,000Feb 03, 2023, 04:45 PM
Noci DarleneChief Development OfficerFeb 02, 2023 Sale$29.563,00088,6671,012Feb 03, 2023, 04:45 PM
Miller Deborah AnnChief Legal OfficerJan 17, 2023 Option Exercise$6.892,00013,7802,000Jan 19, 2023, 04:48 PM
Miller Deborah AnnChief Legal OfficerJan 17, 2023 Sale$32.622,00065,2421,291Jan 19, 2023, 04:48 PM
Shair MatthewDirectorJan 04, 2023 Sale$28.0418,300513,1061,946,982Jan 06, 2023, 04:42 PM
Miller Deborah AnnChief Legal OfficerDec 15, 2022 Option Exercise$6.892,00013,7802,000Dec 16, 2022, 04:48 PM
Miller Deborah AnnChief Legal OfficerDec 15, 2022 Sale$29.982,00059,955676Dec 16, 2022, 04:48 PM
Noci DarleneChief Development OfficerDec 15, 2022 Option Exercise$1.084,2004,5364,200Dec 16, 2022, 04:46 PM
Noci DarleneChief Development OfficerDec 15, 2022 Sale$29.914,200125,635800Dec 16, 2022, 04:46 PM
Shair MatthewDirectorDec 07, 2022 Sale$31.1718,300570,4581,968,592Dec 09, 2022, 04:45 PM
Miller Deborah AnnChief Legal OfficerNov 15, 2022 Option Exercise$6.892,00013,7802,000Nov 17, 2022, 04:52 PM
Miller Deborah AnnChief Legal OfficerNov 15, 2022 Sale$31.912,00063,8141,400Nov 17, 2022, 04:52 PM
Noci DarleneChief Development OfficerNov 15, 2022 Option Exercise$1.084,2004,5364,200Nov 17, 2022, 04:46 PM
Noci DarleneChief Development OfficerNov 15, 2022 Sale$31.994,200134,3503,300Nov 17, 2022, 04:46 PM
Flynn James EDirectorNov 03, 2022 Buy$33.50650,00021,775,000650,000Nov 07, 2022, 06:24 PM
Shair MatthewDirectorNov 03, 2022 Sale$29.6037,9391,123,1152,012,587Nov 04, 2022, 04:45 PM
Shair MatthewDirectorNov 02, 2022 Sale$32.0495,4553,058,3372,107,153Nov 04, 2022, 04:45 PM
Hack Andrew A. F.DirectorNov 03, 2022 Buy$33.50149,2534,999,9763,577,267Nov 03, 2022, 04:15 PM
Noci DarleneChief Development OfficerOct 28, 2022 Option Exercise$1.081,0001,0801,000Nov 01, 2022, 05:24 PM
Noci DarleneChief Development OfficerOct 28, 2022 Sale$40.251,00040,2500Nov 01, 2022, 05:24 PM
Miller Deborah AnnChief Legal OfficerOct 28, 2022 Option Exercise$6.898,96861,7908,968Nov 01, 2022, 05:23 PM
Miller Deborah AnnChief Legal OfficerOct 28, 2022 Sale$38.868,968348,4706,968Nov 01, 2022, 05:23 PM
Noci DarleneChief Development OfficerOct 14, 2022 Option Exercise$1.084,2004,5364,200Oct 14, 2022, 04:48 PM
Noci DarleneChief Development OfficerOct 14, 2022 Sale$21.414,20089,9220Oct 14, 2022, 04:48 PM
Shair MatthewDirectorOct 07, 2022 Sale$18.7012,613235,8252,114,804Oct 07, 2022, 04:52 PM
Shair MatthewDirectorOct 06, 2022 Sale$19.008,608163,5522,127,305Oct 07, 2022, 04:52 PM
Shair MatthewDirectorOct 05, 2022 Sale$19.227,884151,5302,135,913Oct 07, 2022, 04:52 PM
Shair MatthewDirectorSep 15, 2022 Sale$18.345,650103,6212,143,797Sep 16, 2022, 04:48 PM
Shair MatthewDirectorSep 14, 2022 Sale$18.3613,151241,4522,149,447Sep 16, 2022, 04:48 PM
Noci DarleneChief Development OfficerSep 15, 2022 Option Exercise$1.084,2004,5364,200Sep 16, 2022, 04:45 PM
Noci DarleneChief Development OfficerSep 15, 2022 Sale$18.144,20076,1880Sep 16, 2022, 04:45 PM
Noci DarleneChief Development OfficerAug 24, 2022 Option Exercise$1.081,6041,7321,604Aug 25, 2022, 04:15 PM
Noci DarleneChief Development OfficerAug 24, 2022 Sale$17.031,60427,3160Aug 25, 2022, 04:15 PM
Noci DarleneChief Development OfficerAug 15, 2022 Option Exercise$1.082,5962,8042,596Aug 17, 2022, 04:17 PM
Noci DarleneChief Development OfficerAug 15, 2022 Sale$17.022,59644,1840Aug 17, 2022, 04:17 PM
Noci DarleneChief Development OfficerJul 18, 2022 Option Exercise$1.08100108100Jul 19, 2022, 05:01 PM
Noci DarleneChief Development OfficerJul 15, 2022 Option Exercise$1.083,7824,0853,782Jul 19, 2022, 05:01 PM
Noci DarleneChief Development OfficerJul 19, 2022 Option Exercise$1.08318343318Jul 19, 2022, 05:01 PM
Noci DarleneChief Development OfficerJul 18, 2022 Sale$17.071001,7070Jul 19, 2022, 05:01 PM
Noci DarleneChief Development OfficerJul 15, 2022 Sale$17.293,78265,379300Jul 19, 2022, 05:01 PM
Noci DarleneChief Development OfficerJul 19, 2022 Sale$17.023185,4120Jul 19, 2022, 05:01 PM
Shair MatthewDirectorJul 15, 2022 Sale$18.292,00036,5802,162,598Jul 15, 2022, 04:51 PM
Shair MatthewDirectorJul 13, 2022 Sale$18.251001,8252,164,598Jul 15, 2022, 04:51 PM
Noci DarleneSee RemarksJul 07, 2022 Option Exercise$1.0816,80018,14416,800Jul 08, 2022, 04:17 PM
Noci DarleneSee RemarksJul 07, 2022 Sale$17.6116,800295,8480Jul 08, 2022, 04:17 PM
Turner Christopher DurantChief Medical OfficerMay 17, 2022 Option Exercise$6.8914,51399,99514,513May 19, 2022, 04:36 PM
Noci DarleneSee RemarksFeb 15, 2022 Option Exercise$1.084,2004,5364,200Feb 16, 2022, 07:09 PM
Noci DarleneSee RemarksFeb 15, 2022 Sale$17.174,20072,1140Feb 16, 2022, 07:09 PM
Hack Andrew A. F.DirectorAug 02, 2021 Buy$17.00735,00012,495,0003,428,014Aug 04, 2021, 05:12 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Shair MatthewDirector03/25/2024153,546
Shair MatthewDirector03/25/20242,878,982
Noci DarleneChief Development Officer03/22/2024154,800
Noci DarleneChief Development Officer03/22/20241,550,229
Conley EmilyDirector03/15/2024124,797
Conley EmilyDirector03/15/20241,078,883
Shair MatthewDirector12/28/20233,663,492
Shair MatthewDirector12/27/202375,170
Shair MatthewDirector12/26/20235,228,345
Protopapas AnnaDirector12/18/202346,800
Protopapas AnnaDirector12/18/2023378,350
Noci DarleneChief Development Officer12/18/2023188,139
Noci DarleneChief Development Officer12/18/20233,032,800
Miller Deborah AnnChief Legal Officer12/19/202394,650
Miller Deborah AnnChief Legal Officer12/18/2023920,331
Miller Deborah AnnChief Legal Officer12/19/2023375,000
Miller Deborah AnnChief Legal Officer12/18/20232,505,548
Balcom AlexandraChief Financial Officer12/18/202332,400
Balcom AlexandraChief Financial Officer12/18/20232,274,600
Shair MatthewDirector11/28/2023566,303
Noci DarleneChief Development Officer11/01/20233,240
Noci DarleneChief Development Officer11/01/2023157,975
Shair MatthewDirector10/24/20234,648,872
Turner Christopher DurantChief Medical Officer10/04/202355,086
Turner Christopher DurantChief Medical Officer10/04/2023432,031
Noci DarleneChief Development Officer10/04/2023111,150
Noci DarleneChief Development Officer10/04/20231,119,702
Noci DarleneChief Development Officer10/02/20233,240
Noci DarleneChief Development Officer10/02/2023137,649
Miller Deborah AnnChief Legal Officer09/15/202313,780
Miller Deborah AnnChief Legal Officer09/15/202395,283
Noci DarleneChief Development Officer09/01/20233,240
Noci DarleneChief Development Officer09/01/2023139,692
Miller Deborah AnnChief Legal Officer08/15/202313,780
Miller Deborah AnnChief Legal Officer08/15/202385,310
Noci DarleneChief Development Officer08/01/20233,240
Noci DarleneChief Development Officer08/01/2023149,844
Balcom AlexandraChief Financial Officer07/31/202327,000
Balcom AlexandraChief Financial Officer07/31/20231,224,796
Miller Deborah AnnChief Legal Officer07/28/202344,785
Miller Deborah AnnChief Legal Officer07/28/2023315,380
Turner Christopher DurantChief Medical Officer07/26/202316,295
Turner Christopher DurantChief Medical Officer07/28/202318,362
Turner Christopher DurantChief Medical Officer07/28/2023130,398
Turner Christopher DurantChief Medical Officer07/26/2023110,800
Turner Christopher DurantChief Medical Officer07/24/20231,378
Turner Christopher DurantChief Medical Officer07/20/2023689
Turner Christopher DurantChief Medical Officer07/24/20239,364
Turner Christopher DurantChief Medical Officer07/20/20234,680
Noci DarleneChief Development Officer07/20/202311,816
Noci DarleneChief Development Officer07/19/20234,924
Noci DarleneChief Development Officer07/19/2023205,337
Noci DarleneChief Development Officer07/20/2023494,205
Miller Deborah AnnChief Legal Officer07/17/202313,780
Miller Deborah AnnChief Legal Officer07/17/202386,123
Noci DarleneChief Development Officer07/03/20233,240
Noci DarleneChief Development Officer07/03/2023124,427
Noci DarleneChief Development Officer06/16/20233,132
Noci DarleneChief Development Officer06/15/20231,080
Noci DarleneChief Development Officer06/16/2023131,051
Noci DarleneChief Development Officer06/15/202345,070
Miller Deborah AnnChief Legal Officer06/15/202313,780
Miller Deborah AnnChief Legal Officer06/15/202388,565
Turner Christopher DurantChief Medical Officer06/05/202370,519
Turner Christopher DurantChief Medical Officer06/05/2023459,142
Noci DarleneChief Development Officer06/05/2023648
Noci DarleneChief Development Officer06/05/202327,000
Noci DarleneChief Development Officer06/01/20233,240
Noci DarleneChief Development Officer06/01/2023127,921
Miller Deborah AnnChief Legal Officer05/15/202313,780
Miller Deborah AnnChief Legal Officer05/15/202381,489
Miller Deborah AnnChief Legal Officer05/09/20239,177
Miller Deborah AnnChief Legal Officer05/05/202319,292
Miller Deborah AnnChief Legal Officer05/09/202352,787
Miller Deborah AnnChief Legal Officer05/05/2023110,992
Noci DarleneChief Development Officer05/01/20233,240
Noci DarleneChief Development Officer05/01/2023115,787
Miller Deborah AnnChief Legal Officer05/01/20236,201
Miller Deborah AnnChief Legal Officer05/01/202335,649
Miller Deborah AnnChief Legal Officer04/17/202313,780
Miller Deborah AnnChief Legal Officer04/17/202360,197
Noci DarleneChief Development Officer04/03/20233,240
Noci DarleneChief Development Officer04/03/202379,765
Miller Deborah AnnChief Legal Officer03/15/202313,780
Miller Deborah AnnChief Legal Officer03/15/202356,509
Noci DarleneChief Development Officer02/02/20233,240
Noci DarleneChief Development Officer02/02/202388,667
Miller Deborah AnnChief Legal Officer01/17/202313,780
Miller Deborah AnnChief Legal Officer01/17/202365,242
Shair MatthewDirector01/04/2023513,106
Miller Deborah AnnChief Legal Officer12/15/202213,780
Miller Deborah AnnChief Legal Officer12/15/202259,955
Noci DarleneChief Development Officer12/15/20224,536
Noci DarleneChief Development Officer12/15/2022125,635
Shair MatthewDirector12/07/2022570,458
Miller Deborah AnnChief Legal Officer11/15/202213,780
Miller Deborah AnnChief Legal Officer11/15/202263,814
Noci DarleneChief Development Officer11/15/20224,536
Noci DarleneChief Development Officer11/15/2022134,350
Flynn James EDirector11/03/202221,775,000
Shair MatthewDirector11/03/20221,123,115
Shair MatthewDirector11/02/20223,058,337
Hack Andrew A. F.Director11/03/20224,999,976
Noci DarleneChief Development Officer10/28/20221,080
Noci DarleneChief Development Officer10/28/202240,250
Miller Deborah AnnChief Legal Officer10/28/202261,790
Miller Deborah AnnChief Legal Officer10/28/2022348,470
Noci DarleneChief Development Officer10/14/20224,536
Noci DarleneChief Development Officer10/14/202289,922
Shair MatthewDirector10/07/2022235,825
Shair MatthewDirector10/06/2022163,552
Shair MatthewDirector10/05/2022151,530
Shair MatthewDirector09/15/2022103,621
Shair MatthewDirector09/14/2022241,452
Noci DarleneChief Development Officer09/15/20224,536
Noci DarleneChief Development Officer09/15/202276,188
Noci DarleneChief Development Officer08/24/20221,732
Noci DarleneChief Development Officer08/24/202227,316
Noci DarleneChief Development Officer08/15/20222,804
Noci DarleneChief Development Officer08/15/202244,184
Noci DarleneChief Development Officer07/18/2022108
Noci DarleneChief Development Officer07/15/20224,085
Noci DarleneChief Development Officer07/19/2022343
Noci DarleneChief Development Officer07/18/20221,707
Noci DarleneChief Development Officer07/15/202265,379
Noci DarleneChief Development Officer07/19/20225,412
Shair MatthewDirector07/15/202236,580
Shair MatthewDirector07/13/20221,825
Noci DarleneSee Remarks07/07/202218,144
Noci DarleneSee Remarks07/07/2022295,848
Turner Christopher DurantChief Medical Officer05/17/202299,995
Noci DarleneSee Remarks02/15/20224,536
Noci DarleneSee Remarks02/15/202272,114
Hack Andrew A. F.Director08/02/202112,495,000
Load More Insider Transactions
FUNDS WITH A POSITION IN NUVALENT INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)19,991,02427.16%No changeOther
BLACKROCK INC.2,721,1950.00511%11.98%Other
DRIEHAUS CAPITAL MANAGEMENT LLC937,7280.83%-24.34%Growth
GEODE CAPITAL MANAGEMENT, LLC654,7470.00504%20.06%Other
D. E. SHAW & CO., INC.468,1830.03%47.56%Other
CANDRIAM S.C.A.280,0090.14%-20%Other
TUDOR INVESTMENT CORP ET AL29,1780.02%49.57%Event Driven, Other
D. E. SHAW & CO., INC.10,000 (Call)0.00064%NewOther
AQR CAPITAL MANAGEMENT LLC8,8320.00122%-4.61%Other
CHANGE IN SHARES OUTSTANDING FOR NUVALENT INC
STOCK BUYBACKS FOR NUVALENT INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
9.00%
1Q
12/31/2023
06/30/2023
9.43%
2Q
12/31/2023
03/31/2023
9.74%
3Q
12/31/2023
12/31/2022
15.97%
4Q
12/31/2023
09/30/2022
28.54%
5Q
12/31/2023
06/30/2022
28.78%
6Q
12/31/2023
03/31/2022
28.87%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
9.00%
1Q
06/30/2023
9.43%
2Q
03/31/2023
9.74%
3Q
12/31/2022
15.97%
4Q
09/30/2022
28.54%
5Q
06/30/2022
28.78%
6Q
03/31/2022
28.87%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NUVALENT INC
LOADING...